BASi Announces Validated ‘SEND’ Capabilities and Compliance With FDA’s Standard for Exchange of Nonclinical Data
Bioanalytical Systems, Inc. (BASi) today announced its “SEND” compliance with a fully integrated software solution for streamlining data management and reporting.
